dabrafenib
CDRB436X2X02B
Approved small_molecule active
Quick answer
dabrafenib for Melanoma is a Approved program (small_molecule) at Novartis Pharmaceuticals with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Novartis Pharmaceuticals
- Indication
- Melanoma
- Phase
- Approved
- Modality
- small_molecule
- Status
- active